From Financial Modeling Prep: 2025-03-06 07:00:04

Hologic, Inc. shows strong financial health with a ROIC of 10.04% exceeding its WACC of 7.88%, indicating efficient capital use and value creation. In contrast, Henry Schein, Inc. and DENTSPLY SIRONA Inc. struggle with lower ROIC to WACC ratios, suggesting challenges in generating returns above their cost of capital. ResMed Inc. shines with a ROIC of 20.06% and a WACC of 7.40%, demonstrating superior capital efficiency.



Read more at Financial Modeling Prep:: Hologic, Inc. (NASDAQ:HOLX) Financial Analysis: A …